Menu
Not yet recruiting NCT07708792

Influence of Adjunctive Acids Use on Esthetic Outcomes of Gingival Melanin Depigmentation: A Periodontal-Operative Pilot Randomized Clinical Trial

No phase Interventional Gingival Pigmentation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Citric acid.
Who it may be relevant to
Registry conditions: Gingival Pigmentation. Basic parameters: 18 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This pilot randomized clinical trial aims to evaluate the effect of adjunctive acid application on the esthetic outcomes of gingival melanin depigmentation. Participants with physiologic gingival hyperpigmentation will be randomly assigned to receive conventional gingival depigmentation with or without adjunctive acid application. The primary outcome is the improvement in gingival esthetics, while secondary outcomes include postoperative healing, pain, patient satisfaction, and recurrence of pigmentation. The findings of this study may help identify whether adjunctive acid application improves the clinical outcomes of gingival depigmentation procedures.

Interventions

  • Drug Citric acid
    Adjunctive topical application of citric acid during gingival melanin depigmentation according to the study protocol to evaluate its effect on esthetic outcomes and healing.

Primary outcome measures

  • Esthetic Outcome of Gingival Melanin Depigmentation [Time frame: 3 months after treatment]

Eligibility criteria

Inclusion criteria

  • Adults aged 18-50 years.
  • Presence of physiologic gingival melanin pigmentation requiring treatment.
  • Good general health.
  • Good periodontal health or a healthy periodontium after initial periodontal therapy.
  • Willingness to participate and provide written informed consent.
  • Ability to attend all follow-up visits.

Exclusion criteria

  • Current smokers or tobacco users.
  • Pregnancy or breastfeeding.
  • History of systemic diseases that may affect wound healing (e.g., uncontrolled diabetes or immunocompromised conditions).
  • Use of medications known to affect gingival pigmentation or wound healing.
  • Previous gingival depigmentation treatment in the study area.
  • Active periodontal disease or oral infection. Known allergy or hypersensitivity to the study acid or related materials.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07708792 · 83

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗